Get the Stockscreener App
8.45
3.30%
0.27
After Hours:
8.87
0.42
+4.97%
Optimizerx Corp stock is traded at $8.45, with a volume of 142.64K.
It is up +3.30% in the last 24 hours and up +2.18% over the past month.
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
See More
Previous Close:
$8.18
Open:
$8.17
24h Volume:
142.64K
Relative Volume:
0.29
Market Cap:
$154.02M
Revenue:
$62.81M
Net Income/Loss:
$-13.75M
P/E Ratio:
-10.56
EPS:
-0.8
Net Cash Flow:
$153.00K
1W Performance:
+3.55%
1M Performance:
+2.18%
6M Performance:
+28.03%
1Y Performance:
-11.33%
1-Day Range:
$8.14
$8.58
1-Week Range:
$7.755
$8.58
52-Week Range:
$3.78
$14.13
Optimizerx Corp Stock (OPRX) Company Profile
Name
Optimizerx Corp
Sector
Industry
Phone
248-651-6558
Address
260 CHARLES STREET, WALTHAM, MI
Compare OPRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
8.45 | 154.02M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
215.95 | 36.39B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
53.21 | 9.87B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
40.45 | 7.46B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
84.52 | 7.21B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.45 | 6.30B | 906.14M | -52.62M | 89.62M | -0.3621 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Jul-25-24 | Resumed | B. Riley Securities | Buy |
| Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Feb-02-23 | Resumed | B. Riley Securities | Buy |
| Nov-01-22 | Initiated | Stifel | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| Oct-18-21 | Resumed | B. Riley Securities | Buy |
| Apr-13-21 | Initiated | RBC Capital Mkts | Outperform |
| Jan-03-19 | Initiated | William Blair | Outperform |
View All
Optimizerx Corp Stock (OPRX) Latest News
Kennedy Capital Management LLC Boosts Holdings in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
Analysts Set OptimizeRx Co. (NASDAQ:OPRX) Target Price at $9.06 - MarketBeat
OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment - The Manila Times
Whetstone Capital Advisors LLC Invests $6.56 Million in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
Blair William & Co. IL Reduces Stock Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
Short Interest in OptimizeRx Co. (NASDAQ:OPRX) Grows By 22.0% - MarketBeat
OptimizeRx Co. (NASDAQ:OPRX) Sees Significant Increase in Short Interest - Defense World
OptimizeRx Corporation (NASDAQ:OPRX) is favoured by institutional owners who hold 59% of the company - Yahoo Finance
Bank of New York Mellon Corp Has $426,000 Stock Position in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx Files $75 Million Mixed Shelf - Marketscreener.com
OptimizeRx Corp Files For Mixed Shelf Of Up To $75 MillionSEC Filing - MarketScreener
OptimizeRx Co. (NASDAQ:OPRX) Director James Paul Lang Purchases 321,408 Shares - MarketBeat
Royce & Associates LP Takes Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Corp (NASDAQ: OPRX): The Metrics That Matter Right Now - Stocks Register
OptimizeRx Co. (NASDAQ:OPRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
OptimizeRx Corp SEC 10-K Report - TradingView
OptimizeRx director James Lang purchases $2.44 million in common stock By Investing.com - Investing.com South Africa
OptimizeRx director James Lang purchases $2.44 million in common stock - Investing.com
OptimizeRx (OPRX) to Release Quarterly Earnings on Wednesday - MarketBeat
Q1 Earnings Forecast for OptimizeRx Issued By B. Riley - MarketBeat
Head to Head Review: OptimizeRx (NASDAQ:OPRX) & CFN Enterprises (OTCMKTS:CNFN) - Defense World
Why OptimizeRx Corp. (OPRX) Soared Last Week? - Insider Monkey
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates - MSN
Roth Capital Predicts OptimizeRx's Q1 Earnings (NASDAQ:OPRX) - MarketBeat
Research Analysts Issue Forecasts for OptimizeRx Q1 Earnings - Defense World
OptimizeRx (NASDAQ:OPRX) Releases Earnings Results, Misses Expectations By $0.11 EPS - MarketBeat
OptimizeRx (NASDAQ:OPRX) Upgraded at B. Riley - MarketBeat
OptimizeRx Corp [OPRX] CEO makes an insider purchase of 20,000 shares worth 0.1 million. - Knox Daily
OptimizeRx Corporation (NASDAQ:OPRX) Q4 2024 Earnings Call Transcript - Insider Monkey
OptimizeRx Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
OptimizeRx Corp (OPRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Margin Expansion - Investing.com Canada
OptimizeRx Q4 results ‘at odds with muted’ outlook, says Roth MKM - TipRanks
OptimizeRx Clocks Double-Digit Revenue Growth In Q4, Forecasts Sales Of At Least $100 Million - Benzinga
Earnings call transcript: OptimizeRx Q4 2024 sees revenue growth, stock surges By Investing.com - Investing.com South Africa
OPTIMIZERx earnings beat by $0.04, revenue topped estimates - Investing.com
Earnings call transcript: OptimizeRx Q4 2024 sees revenue growth, stock surges - Investing.com UK
OptimizeRx Corp reports results for the quarter ended December 31Earnings Summary - TradingView
OptimizeRx Corporation Provides Earnings Guidance for the Full Year 2025 -March 12, 2025 at 07:30 am EDT - MarketScreener
OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results - TradingView
OPTIMIZERX Earnings Results: $OPRX Reports Quarterly Earnings - Quiver Quantitative
ForexTV | Small Business Resources - ForexTV.com
Optimizerx Corp Stock (OPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Optimizerx Corp Stock (OPRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Silvestro Stephen L | Chief Commercial Officer |
Mar 01 '25 |
Option Exercise |
0.00 |
1,928 |
0 |
121,886 |
| Odence-Ford Marion | Chief Legal Officer & CHRO |
Mar 01 '25 |
Option Exercise |
0.00 |
771 |
0 |
70,544 |
| KLEMA CATHY | Director |
Feb 02 '25 |
Option Exercise |
0.00 |
5,109 |
0 |
11,752 |
| Odence-Ford Marion | General Counsel and CCO |
Dec 19 '24 |
Option Exercise |
0.00 |
3,927 |
0 |
28,383 |
| Silvestro Stephen L | Chief Commercial Officer |
Dec 19 '24 |
Option Exercise |
0.00 |
6,546 |
0 |
83,424 |
| Besch Doug | Chief Product Officer |
Dec 19 '24 |
Option Exercise |
0.00 |
1,964 |
0 |
12,160 |
| Stelmakh Edward | CFO/COO |
Dec 19 '24 |
Option Exercise |
0.00 |
5,237 |
0 |
38,603 |
| FEBBO WILLIAM J | CEO |
Dec 12 '24 |
Buy |
5.01 |
20,000 |
100,220 |
601,253 |
| Odence-Ford Marion | General Counsel and CCO |
Nov 08 '24 |
Option Exercise |
0.00 |
1,785 |
0 |
24,980 |
| Stelmakh Edward | CFO/COO |
Oct 11 '24 |
Option Exercise |
0.00 |
8,222 |
0 |
35,432 |
0.05%
0.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):